Kiadis Crushed By EMA Rejection Of T-Cell Therapy

Launch Hopes For ATIR101 Pushed Back A Few Years

Climate change
Changing treatment landscape scuppers Kiadis approval hopes • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D